STOCK TITAN
  1. Home
  2. Sec-filings
  3. COR
  4. [ARS] Cencora, Inc. SEC Filing

[ARS] Cencora, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
ARS

Rhea-AI Filing Summary

Analyzing...
ARS - Cencora, Inc.

ARS Filing - Cencora, Inc.

This filing is available as a PDF document.

Filing Type: ARS

Company: Cencora, Inc. (COR)

Acceptance Date: 2026-01-22T16:29:18.000Z

View PDF Document

Source: View Original Filing on SEC EDGAR

Stock COR logo
Cencora Inc.

NYSE:COR

COR Rankings

#234 Ranked by Market Cap
#1273 Ranked by Dividends
#304 52-Week Gainer
#992 YTD Gainer
#994 Monthly Gainer

COR Latest News

Jan 22, 2026
Cencora Elects Ellen Cooper to Its Board of Directors
Jan 6, 2026
Cencora Announces Date and Time for First Quarter Fiscal 2026 Earnings Release
Dec 15, 2025
Cencora Accelerates OneOncology Acquisition, Extending Solutions Offering for Community Oncology
Nov 5, 2025
Cencora Reports Fiscal 2025 Fourth Quarter and Fiscal Year End Results
Oct 16, 2025
IntrinsiQ Specialty Solutions Expands Data Capabilities to Empower Biopharmaceutical Manufacturers and Physicians with Actionable Insights to Improve Patient Outcomes

COR Latest SEC Filings

Jan 22, 2026
[Form 4] Cencora, Inc. Insider Trading Activity
Jan 22, 2026
[DEF 14A] Cencora, Inc. Definitive Proxy Statement
Jan 22, 2026
[8-K] Cencora, Inc. Reports Material Event
Jan 20, 2026
[144] Cencora, Inc. SEC Filing
Jan 16, 2026
[8-K] Cencora, Inc. Reports Material Event

COR Stock Data

68.38B
185.78M
4.2%
94.03%
3.17%
Medical Distribution
Wholesale-drugs, Proprietaries & Druggists' Sundries
Link
United States
CONSHOHOCKEN